Clinical Trial: Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Ovarian Cancer
Study Type: INTERVENTIONAL
Official Title: Intraoperative Esketamine for Prevention of Depressive Symptoms After Cytoreductive Surgery in Ovarian Cancer: a Controlled, Randomized Clinical Trial
Brief Summary:
The goal of this clinical trial is to learn if intraoperative administration of esketamine would prevent or mitigate postoperative depressive symptoms after cytoreductive surgery in ovarian cancer.The main questions it aims to answer are:Whether a single low dose of esketamine administered would reduce the postoperative depressive symptoms three days after cytoreductive surgery in ovarian cancer?Whether a single low dose of esketamine administered would relief the postoperative sleep disturbance, postoperative…
Read more